Stealth BioTherapeutics Announces Participation at Upcoming OIS, ARVO, & RWC Conferences Press Release / May 1, 2024February 18, 2025
Stealth Biotherapeutics Announces FDA Acceptance of New Drug Application for Elamipretide for the Treatment of Barth Syndrome Press Release / April 8, 2024March 7, 2025
Stealth BioTherapeutics Presents Data of Novel Compound, SBT-589, in Friedreich’s Ataxia Cardiac Models at the Wellcome Trust Mitochondrial Medicine Conference Press Release / March 19, 2024March 6, 2025
